Table 2.

BILAG-2004 scores.

Baseline										6 months
Patient	Biologic	Gen	Muco	Neuro	MSK	Cardio	Renal	Haem	Total score	Gen	Muco	Neuro	MSK	Cardio	Renal	Haem	Total score	BILAG-2004 Response
CD20-to-Belimumab Group
1	Bel	E	A	E	B	E	E	C	21	E	B	E	B	E	E	C	17	PCR
2	Bel	E	B	E	E	E	E	C	9	E	B	E	E	E	E	C	9	NCR
3	Bel	A	C	E	C	D	E	B	22	D	C	E	C	E	A	B	22	NCR
4	Bel	D	B	E	B	D	B	C	25	D	A	E	D	D	A	C	25	NCR
5	Bel	D	B	E	B	D	E	C	17	D	B	E	B	D	E	C	17	NCR
6	Bel	C	B	D	A	A	E	D	33	C	C	D	B	D	E	D	10	PCR
7	Bel	E	E	B	A	D	E	C	21	E	E	B	A	D	E	C	21	NCR
8	Bel	C	B	E	A	E	E	C	22	B	B	E	C	B	E	C	26	NCR
CD20-to-CD20 Group
9	Ocr	B	A	E	B	D	A	C	41	D	C	E	D	D	D	C	2	MCR
10	Ocr	B	E	E	D	E	A	C	21	D	E	E	D	E	D	C	1	MCR
11	Ocr	E	E	B	B	E	E	C	17	E	E	D	C	E	E	C	2	MCR
12	Ofa	E	E	E	E	E	A	A	24	E	E	E	E	E	B	C	9	PCR
13	Ofa	B	A	B	B	E	A	C	49	D	C	D	D	E	C	C	3	MCR
14	Obi	D	A	D	C	E	D	C	14	D	C	D	C	E	D	C	3	MCR

Ocr, Ocrelizumab; Ofa, Ofatumumab; Obi, Obinutuzumab; MCR, major clinical response; PCR, partial clinical response; NCR, no clinical response.